Login / Signup

How does prescribing for antihypertensive products stack up against guideline recommendations? An Australian population-based study (2006-2014).

Andrea L SchafferSallie-Anne PearsonNicholas A Buckley
Published in: British journal of clinical pharmacology (2016)
More than half of antihypertensive initiators conformed to Australian guidelines. Initiation on FDCs and other non-recommended treatments was associated with lower persistence on antihypertensive therapy in the first year. Long-term effectiveness and outcomes may be enhanced by initiating with low dose monotherapy.
Keyphrases